149 related articles for article (PubMed ID: 26089884)
1. Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity.
Lalić K; Jotić A; Rajković N; Singh S; Stošić L; Popović L; Lukić L; Miličić T; Seferović JP; Maćešić M; Stanarčić J; Čivčić M; Kadić I; Lalić NM
Int J Endocrinol; 2015; 2015():390185. PubMed ID: 26089884
[TBL] [Abstract][Full Text] [Related]
2. Decreased Insulin Sensitivity and Impaired Fibrinolytic Activity in Type 2 Diabetes Patients and Nondiabetics with Ischemic Stroke.
Jotic A; Milicic T; Covickovic Sternic N; Kostic VS; Lalic K; Jeremic V; Mijajlovic M; Lukic L; Rajkovic N; Civcic M; Macesic M; Seferovic JP; Stanarcic J; Aleksic S; Lalic NM
Int J Endocrinol; 2015; 2015():934791. PubMed ID: 26089903
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
4. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
5. Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Tretjakovs P; Jurka A; Bormane I; Mikelsone I; Elksne K; Krievina G; Reihmane D; Verbovenko J; Bahs G
Clin Chim Acta; 2012 Jan; 413(1-2):25-9. PubMed ID: 22024218
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 is associated with coronary artery calcium in Type 1 diabetes.
Pratte KA; Barón AE; Ogden LG; Hassell KL; Rewers M; Hokanson JE
J Diabetes Complications; 2009; 23(6):387-93. PubMed ID: 18768333
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.
Toft I; Bønaa KH; Ingebretsen OC; Nordøy A; Birkeland KI; Jenssen T
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):553-9. PubMed ID: 9102176
[TBL] [Abstract][Full Text] [Related]
8. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity.
Psyrogiannis AJ; Alexopoulos DK; Kyriazopoulou VE; Vagenakis AG
Angiology; 1998 Aug; 49(8):607-12. PubMed ID: 9717889
[TBL] [Abstract][Full Text] [Related]
10. Differential response of plasma plasminogen activator inhibitor 1 after weight loss surgery in patients with or without type 2 diabetes.
Mossberg KE; Pournaras DJ; Welbourn R; le Roux CW; Brogren H
Surg Obes Relat Dis; 2017 Jan; 13(1):53-57. PubMed ID: 27387691
[TBL] [Abstract][Full Text] [Related]
11. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
12. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.
Sobel BE; Woodcock-Mitchell J; Schneider DJ; Holt RE; Marutsuka K; Gold H
Circulation; 1998 Jun; 97(22):2213-21. PubMed ID: 9631870
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
Koistinen HA; Dusserre E; Ebeling P; Vallier P; Koivisto VA; Vidal H
Diabetes Metab Res Rev; 2000; 16(5):364-9. PubMed ID: 11025560
[TBL] [Abstract][Full Text] [Related]
14. HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study.
Mossmann M; Wainstein MV; Gonçalves SC; Wainstein RV; Gravina GL; Sangalli M; Veadrigo F; Matte R; Reich R; Costa FG; Bertoluci MC
Diabetol Metab Syndr; 2015; 7():100. PubMed ID: 26753001
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians.
Nagi DK; Foy CA; Mohamed-Ali V; Yudkin JS; Grant PJ; Knowler WC
Metabolism; 1998 May; 47(5):622-6. PubMed ID: 9591757
[TBL] [Abstract][Full Text] [Related]
16. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
[TBL] [Abstract][Full Text] [Related]
17. The relationships between insulin and plasminogen activator inhibitor 1 levels: assessment in groups of subjects with dyslipidaemia and hypertension.
Akanji AO; Al-Shayji I
Clin Chim Acta; 1998 Jun; 274(1):41-52. PubMed ID: 9681596
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction of coronary arteries in subjects without diabetes: An association with both insulin resistance and impaired insulin secretion response.
Lalić K; Nedeljković M; Jotić A; Babić R; Rajković N; Popović L; Lukić L; Miličić T; Singh Lukač S; Stošić L; Maćešić M; Rasulić I; Gajović JS; Lalić NM
Diabetes Res Clin Pract; 2018 May; 139():179-187. PubMed ID: 29526680
[TBL] [Abstract][Full Text] [Related]
20. Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance.
Hadigan C; Meigs JB; Rabe J; D'Agostino RB; Wilson PW; Lipinska I; Tofler GH; Grinspoon SS;
J Clin Endocrinol Metab; 2001 Feb; 86(2):939-43. PubMed ID: 11158071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
